Global Burden of Melanoma Considerable, Set to Rise by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Five antihypertensive drug classes were analyzed separately and were also compared to all other treatment groups, including placebo.
CXR-LC model had better discrimination than CMS eligibility, similar performance to PLCO Model 2012.
Pooled prevalence rates of breast cancer, digestive cancer, skin cancer were 2, 2, and 1 percent, respectively.
Statistically nonsignificant reduction in incidence rate of obesity-related cancers seen in Look AHEAD trial.
In a recent analysis, the prevalence and age at diagnosis of 4 common cancers was compared in individuals with and without specific types of pre-existing disabilities.
Prospective study shows increased risk for esophageal, gastric adenocarcinoma in two large cohorts.
The development of asthma was found to be associated with an increased risk for subsequent cancer.
The incidence of breast cancer for postmenopausal women included in the NIH-AARP study was evaluated with respect to level of outdoor light at night.
This study used data from the Nurses’ Health Study (NHS) and NHS2 to explore the association between height, number of nevi, and risk of invasive melanoma.